Cargando…
Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses
Anticytokine therapies have been promulgated in gram-negative sepsis as a means of preventing or neutralizing excessive production of proinflammatory cytokines. However, systemic administration of cytokine inhibitors is an inefficient means of targeting excessive production in individual tissue comp...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192075/ https://www.ncbi.nlm.nih.gov/pubmed/7760015 |
Ejemplares similares
-
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
Publicado: (1993) -
Interleukin 10 protects mice from lethal endotoxemia
Publicado: (1993) -
Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor
Publicado: (1992) -
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
Publicado: (1994) -
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
Publicado: (1991)